During inflammation, myeloperoxidase (MPO) accumulates within the subendothelial matrix and produces the reactive oxidant hypochlorous acid (HOCl). Results: Subendothelial MPO catalyzes focal, HOCl-mediated matrix oxidation that disrupts cell-matrix adhesion and alters adhesiondependent cell signaling. Conclusion: MPO disrupts endothelial integrity and promotes cell signaling by targeted subendothelial matrix oxidation. Significance: MPO-mediated matrix oxidation has important implications for endothelial integrity and function during inflammation.
SUMMARY
The vascular endothelium performs vital functions in cardiovascular homeostasis by regulating the initiation and resolution of inflammatory responses and by controlling vascular tone. An important function of the endothelium in this regard is its production of nitric oxide (NO), which exerts anti-inflammatory actions by inhibiting leukocyte adhesion, inhibits platelet aggregation and regulates vascular tone by signaling for vasodilation in the adjacent vascular smooth muscle cells (1) . The homeostatic properties of the endothelium are also dependent on its function as a continuous, semi-permeable barrier that tightly regulates the passage of nutrients, macromolecules, fluid and cells between the blood and the interstitial space (2, 3) . Inflammatory vascular diseases such as atherosclerosis are characterized by endothelial dysfunction manifested as a reduction in the bioactivity of endothelial-derived NO (1) and a loss of endothelial barrier integrity leading to endothelial hyper-permeability (4, 5) . Enhanced vascular oxidative stress during inflammation is implicated as a principal cause of compromised endothelial NO signaling (1) and barrier function (2, 3) and accordingly there is significant interest in understanding the oxidative reactions involved.
Considerable clinical and experimental evidence supports that myeloperoxidase (MPO), an oxidant-generating heme enzyme released by activated leukocytes, plays a pathogenic role in impairing the signaling and vasodilatory function of endothelium-derived NO during inflammatory vascular disease. Thus, circulating MPO levels are elevated in coronary artery disease patients and the extent of this increase is an independent predictor of the incidence of endothelial dysfunction manifested as impaired endothelium-dependent vasorelaxation (6, 7) , as well as the prevalence and degree of coronary artery disease and clinical event risk in patients with acute coronary syndromes (8, 9) . Inflammatory stimuli that increase circulating MPO levels promote endothelial dysfunction in healthy animals and humans, with a deficiency in functional MPO conferring protection (10, 11) . Intravascular administration of MPO also impairs endothelialdependent vasorelaxation (11) . Circulating MPO rapidly leaves the circulating compartment by binding to and transcytosing the endothelium, resulting in its accumulation within the subendothelial matrix, where it is anatomically positioned to impair the signaling and vasodilatory function of endothelium-derived NO by acting as a NO oxidase (10, 12, 13) .
Subendothelial-localized MPO is not only positioned to interfere with NO signaling, but to generate reactive oxidants capable of altering the structure and function of extracellular matrix proteins (12, (14) (15) (16) . The potent chlorinating oxidant hypochlorous acid (HOCl) is the principal oxidant produced by MPO and is generated by oxidation of chloride ions (Cl -) in the presence of the co-substrate hydrogen peroxide (H2O2) (17, 18) . Thiocyanate (SCN − ) and nitrite (NO2 − ) are also significant physiological substrates that divert the enzyme from HOCl production to the generation of the thiol-reactive oxidant hypothiocyanous acid (HOSCN) and the nitrating radical nitrogen dioxide (NO2  ), respectively (18) . Various studies support that subendothelial matrix proteins are significant oxidative targets for MPOderived oxidants. Thus, MPO transcytosed by cultured endothelial cells binds to adhesive matrix substrate fibronectin, conferring specificity of MPO-catalyzed tyrosine nitration to this protein (12) . In atherosclerotic coronary arteries and other inflamed vascular tissue from humans, MPO is characteristically found deposited within the subendothelium where it co-localizes with fibronectin-containing extracellular matrix and tyrosine-nitrated proteins (19) . Extracellular deposits of MPO and HOCl-modified proteins are similarly detected within the vascular endothelium of human atherosclerotic arteries (20, 21) .
While oxidative modification of subendothelial matrix proteins by MPO-derived oxidants is a characteristic event during inflammatory vascular disease, the implications of this for endothelial cell morphology, signaling and phenotype are largely unknown. In the current study, we show that endothelial-transcytosed MPO mediates HOCl-dependent subendothelial matrix oxidation, involving covalent crosslinking of fibronectin, and that this triggers cell-matrix deadhesion driven by actomyosin-dependent tensile stress. We provide evidence that de-adhesion in response to HOCl-mediated matrix oxidation drives changes in key adhesion-dependent signaling processes and that diversion of MPO from HOCl production by SCN − or NO2 − attenuates de-adhesion and associated signaling responses, despite the latter supporting MPOcatalyzed matrix nitration. The ability of transcytosed MPO to disrupt endothelial integrity by targeted, HOCl-mediated subendothelial matrix oxidation may have important implications for the regulation of endothelial signaling and function during inflammation.
EXPERIMENTAL PROCEDURES
Cell culture-Bovine aortic endothelial cells (ECs, Lonza; passages 4 -9) were cultured in EBM-2 medium (Lonza) and routinely passaged on gelatin-coated tissue culture flasks.
Cell Experiments-For experiments with ECs containing transcytosed MPO, ECs were initially cultured to confluence in EBM-2 medium (Lonza; with hydrocortisone omitted) on gelatin (Sigma; coated at 100 g/ml in PBS, 20 min, 22C For experiments with ECs adhered to fibronectin as the sole adhesive substrate, surfaces were first coated with bovine fibronectin (Sigma; 5 g/ml / 22.7 nM in PBS, 2 h, 37C) and then blocked with BSA (0.2% in PBS, 0.5 h, 37C) prior to seeding of cells in serum-free media (medium-199 containing 1% BSA; 1 ml at 5  10 5 cells/ml in 12-well plates, 200 l at 2.5  10 5 cells/ml in 96-well plates). These cell seeding densities yielded a near-confluent layer of adherent cells within 2 h. In experiments to examine a role for fibronectin-bound MPO on EC adhesion, MPO was first bound to fibronectincoated surfaces (20 nM MPO in HBSS, 0.5 h, 37C, with subsequent washing) prior to the seeding of cells. For surface binding of proteins, volumes were selected to ensure uniformity of protein coating, expressed relative to the adhesion area of cells (i.e. g protein/mm 2 ; 1 ml for 12-well plates, 80 l for 96-well plates). ECs adhered to fibronectin or MPO-bearing fibronectin coated surfaces were then subjected to experimental treatments in the same manner as described above for ECs containing transcytosed MPO.
For experiments to measure the propensity of ECs to adhere to fibronectin-bound surfaces previously exposed to MPO-derived oxidants, surfaces with MPO-bearing fibronectin were first treated with oxidants in the same manner as MPOcontaining ECs (see above). Oxidant-exposed surfaces were then incubated with Met (10 mM) for 10 min to quench residual reactive, surfacebound protein chloramines followed by washing, seeding of ECs and measurement of cell adhesion by cell substrate impedance.
Experiments with purified fibronectin-Purified bovine fibronectin (Sigma; 100 nmol/L, twice desalted on PD MiniTrap G-25 columns, GE Healthcare) was oxidized by pre-incubation with MPO (100 nM) for 15 min and exposure to H2O2 (2 -50 μM) for 1 h in the presence and absence of 1 mM Met, 100 μM, ABAH, 100 μM SCN − or 100 μM NO2 − .
Real time quantification of cell adhesion by cellsubstrate impedance-Cell-substrate impedance at the surface of 96-well gold microelectrode arrays (E-plate 96 ® , Roche), expressed as 'cell index', a dimensionless value proportional to the area of cell-substrate contact (24), was measured continuously following seeding of ECs and subsequent treatments by an xCelligence ® system (Roche). During measurements, electrode arrays were housed in an incubator port maintained at 37°C with 5% CO2 saturation. The relative number of attached ECs on electrode surfaces was quantified by crystal violet staining, as previously detailed (16) .
Live cell imaging-Differential interference contrast (DIC) images of live cells on gelatin-or fibronectin-coated 35mm glass-bottomed culture dishes (Fluorodish, World Precision Instruments) were recorded at 37C on a heated stage at 5 s intervals using a 63 water objective on a Leica TCS SP5 microscope. The projected area of randomly selected cells was quantified by manually tracing the membrane edge and quantifying the number of enclosed pixels using ImageJ (NIH). Change in area of individual cells over time was fitted to a single exponential decay using non-linear regression (least squares fitting; Prism 5, GraphPad Software) to determine the half-life of cell contraction.
Measurement of H2O2-Cellular metabolism of exogenously added H2O2 was measured using an Amplex Red kit according to the manufacturer's instructions (Molecular Probes).
Western blotting-Following experiments, cell proteins and purified proteins were immediately harvested into reducing loading buffer. Proteins were separated on 3-8% Tris/Acetate NuPAGE Immunofluorescence-Cells on glass coverslips were processed for immunostaining by fixing with 4% paraformaldehyde (22C, 20 min) and quenching free aldehydes with NH4Cl (50 mM) for 5 min prior to washing in PBS. Cells were immunostained using mouse monoclonal antibodies against fibronectin (1:100), HOCloxidized protein (2D10G9) (1:50) and paxillin (1:1000) or rabbit polyclonal antibodies against MPO (1:100) and fibronectin (1:100). Cy2-conjugated goat anti-mouse (green) and Cy3-conjugated donkey anti-rabbit (red) antibodies were employed as secondary antibodies. Cell nuclei were stained with DAPI (1:2000) and Factin was stained with Alexa 555-phalloidin (Invitrogen; 1:500). After washing with PBS, cells were mounted in Elvanol (Mowiol 4-88, Hoechst, Frankfurt, Germany). Laser confocal fluorescence images were recorded at room temperature using a 63 oil objective on a Leica TCS SP5 microscope. Reconstructions of confocal images were rendered using Imaris software.
Statistics-Statistical analyses were performed using one-way ANOVA with Newman Keul's post-hoc testing with Prism 5 software. Statistical significance was accepted for p values <0.05.
RESULTS

Endothelial-transcytosed
MPO accumulates within the subendothelium where it oxidatively crosslinks matrix fibronectin in a HOCl-dependent manner-Incubation of confluent monolayers of ECs with MPO resulted in its uptake and accumulation within the subendothelial compartment, where it co-localized with matrix fibronectin (FIG. 1A) , observations consistent with a previous study by Baldus et al. (12) . ECs containing transcytosed MPO consumed exogenously added H2O2 at significantly enhanced rates compared to control cells (FIG. 1C) . Laser confocal microscopy and immunofluorescence showed that H2O2 consumption by MPOcontaining ECs was accompanied by the formation of HOCl-oxidized protein within the subendothelial matrix, which co-localized with matrix fibronectin (FIG. 1B) . Western blot analysis of protein extracts of these cells revealed extensive fibronectin crosslinking, reflected by loss of the parent fibronectin band and generation of non-reducible, high molecular weight (>250 kDa) protein aggregates that were recognized by antibodies directed against fibronectin and HOCloxidized protein (FIG. 2A) . Production of HOCloxidized proteins and fibronectin crosslinking were absent in control ECs treated with H2O2 alone (FIG. 1B, FIG. 2A) . Purified bovine fibronectin was similarly converted into HOClmodified, high molecular weight aggregates by exposure to MPO in the presence of H2O2 (FIG.  2B) . Inclusion of the MPO inhibitor ABAH or the HOCl-scavenger methionine (Met) prevented fibronectin cross-linking and generation of HOCloxidized protein within cells (FIG. 2C) and with purified fibronectin (FIG. 2D) , confirming MPOderived HOCl as the damaging species. Notably, HOCl derived from low micromolar concentrations of H2O2 (10 μM) by endothelialtranscytosed MPO efficiently oxidized matrix fibronectin, as judged by the loss of the parent fibronectin band, whilst equivalent doses of reagent HOCl added as a bolus to the apical endothelial surface were ineffective (FIG. 2A) . These data establish that transcytosed MPO mediates targeted matrix oxidation by producing HOCl focally within the subendothelial compartment. 3A) and with purified fibronectin (FIG. 3B) . NO2 − also blocked the formation of HOCloxidized protein and attenuated fibronectin modification/crosslinking and promoted the generation of 3-nitrotyrosine, detected on high molecular weight protein aggregates, both in ECs (FIG. 3A) and on purified fibronectin (FIG. 3B) . To identify the oxidant responsible for mediating fibronectin crosslinking in the presence of NO2 − we added Met, which scavenges HOCl but not NO2  (27) . Inclusion of Met suppressed fibronectin crosslinking and caused the majority of 3-nitrotyrosine reactive protein to shift from high molecular weight aggregated material to a single band that co-migrated with the parent fibronectin band, both in ECs (FIG. 3C) and with purified fibronectin (FIG. 3D) . Thus, while endothelialtranscytosed MPO simultaneously promotes covalent crosslinking and nitration of matrix fibronectin in the presence of NO2 − , covalent fibronectin crosslinking is mediated primarily by HOCl.
MPO disrupts the cell-adhesive function of fibronectin in a HOCl-dependent manner-We next addressed the functional consequences of fibronectin oxidation by MPO, measured by its ability to support EC attachment and spreading. In these studies, MPO was first bound to fibronectincoated surfaces, unbound MPO removed by washing and the MPO-bearing fibronectin surfaces exposed to H2O2 for 30 min. EC attachment and spreading on native and MPO-oxidized fibronectin was then measured in real time using a cellsubstrate impedance electrode.
ECs seeded on native fibronectin in serum-free media were fully attached and spread within 2 h (FIG. 4A) . Cell-substrate impedance values in fully-adhered cells, quantified as 'cell index' (a value proportional to the area of cell-matrix contact (24)), correlated linearly with cell number and increased with the density of fibronectin coating (20 g/mL) ( Supplementary FIG. 2) . Background EC adhesion levels on surfaces without fibronectin were negligible ( Supplementary. FIG. 2) , confirming that adhesion was solely dependent on this substrate.
Binding of MPO (20 nM) to approximately equimolar concentrations of fibronectin (coated at 5 g/ml / 22 nM) prior to cell seeding did not alter the rate or extent of cell attachment and spreading, establishing that MPO does not mask fibronectin motifs that support EC adhesion (FIG. 4A) . Pretreatment of the MPO-bearing fibronectin with low micromolar doses of H2O2 (≤10 μM) markedly impaired its ability to support subsequent EC attachment and spreading, with this loss of adhesive function abrogated by scavenging HOCl with Met and inhibiting MPO with ABAH (FIG. 4B) . The MPO-dependent impairment of fibronectin's cell adhesive function was also blocked by inclusion of SCN − or partially attenuated by NO2 − (FIG. 4C) . In reactions with NO2 − , HOCl scavenging by Met completely preserved the cell adhesive function of fibronectin (FIG. 4C) , despite the ability of MPO to catalyze tyrosine nitration of fibronectin under these conditions (FIGS. 3C, 3D). These findings establish that covalent modification/crosslinking of fibronectin by MPO-derived HOCl disrupts its cell adhesive function and that suppression of HOCl-mediated oxidative modification by SCN − and NO2
− protects against this loss of function.
Subendothelial MPO induces EC de-adhesion in a
HOCl-dependent manner-Having established that MPO-derived HOCl disrupts the cell adhesive function of fibronectin (FIG. 4) and that fibronectin is an important target for HOCl produced by subendothelial MPO (FIGS. 1, 2) , we next examined the capacity of endothelialtranscytosed MPO to alter established EC cellmatrix adhesion. To more specifically address the potential role of fibronectin oxidation by subendothelial-localized MPO in altering EC cellmatrix adhesion, we performed equivalent studies with ECs adhered on fibronectin as the sole adhesive substrate. In these studies, MPO was first incorporated directly onto fibronectin-coated surfaces (as detailed in FIG. 4) , ECs allowed to fully adhere for >2 h (cf . FIG. 4A ) and changes in EC adhesion monitored after initiating MPO activity by exposure to H2O2. Changes in EC cellmatrix adhesion elicited by oxidant production by transcytosed or fibronectin-bound MPO were quantified in real time using a cell-substrate impedance biosensor. In ECs adhered on MPO-bearing fibronectin, H2O2 exposure provoked a rapid, time-dependent (FIG. 5A; p < 0.001 relative to control cells at 2 min at 10 μM H2O2) and dose-dependent (FIG.  5B) loss in cell-matrix contact. Quantification of ECs adhered to impedance electrodes by Crystal violet staining revealed that this decrease in cellmatrix contact was independent of changes to the number of attached cells (Supplementary FIG.  3A) . ECs not only maintained cell attachment but remained viable during oxidant treatment, revealed by their ability to re-establish adhesion to control levels following the addition of fresh media (Supplementary FIG. 3B) . A similarly rapid loss of cell-matrix contact in response to H2O2 exposure was recapitulated in ECs containing transcytosed MPO (FIG. 6A) . No loss of adhesion was detected in ECs exposed to equivalent doses of H2O2 in the absence of MPO (FIGS. 5A, 6A) . Live cell imaging of MPO-containing EC exposed to H2O2 by differential interference contrast (DIC) microscopy (ECs adhered on MPO-bearing fibronectin -Supplementary Movie 1; ECs containing transcytosed MPO -Supplementary Movie 2, with representative frames at 0 and 2 min after H2O2 exposure shown in FIG. 6C) revealed that the losses in cell-matrix contact were due to rapid membrane retraction and 'rounding up' of cells (i.e. 'de-adhesion') and confirmed that all cells remained attached to the substratum (Supplementary Movies 1 and 2) .
Supplementation of ECs adhered on MPObearing fibronectin with Met or ABAH (FIG. 5B) and SCN -or NO2 - (FIG. 5C) prior to H2O2 exposure attenuated MPO-mediated de-adhesion. The residual de-adhesion observed in the presence of SCN -and NO2 -was completely prevented by scavenging spurious amounts of HOCl with Met (FIG. 5C) . Inclusion of Met also completely abrogated de-adhesion in ECs containing transcytosed MPO and treated with H2O2 in the absence or presence of SCN -and NO2 - (FIG. 6B) . Overall, these data establish that subendothelial-localized MPO triggers cell-matrix de-adhesion in a HOCl-dependent manner, and support that this involves disruption of the celladhesive function of fibronectin. Moreover, they identify that SCN -and NO2 -attenuate MPOinduced de-adhesion in accordance with their capacity to suppress HOCl-mediated damage to fibronectin (FIG. 3) .
EC de-adhesion induced by subendothelial MPO is linked with
HOCl-dependent changes in focal adhesion and cytoskeletal signaling-Cell-matrix adhesion involves the assembly of membrane domains called focal adhesions that co-ordinate cellular responses to local changes in the chemical and physical state of the extracellular matrix by transducing 'outside-in' signaling (28, 29) . Phosphorylation of the focal adhesion protein paxillin at Tyr-118 has emerged as a major mechanobiological signaling 'switch' that regulates responses to changes in cell-matrix adhesion, with loss of force transduction between the cell membrane and underlying matrix upregulating paxillin phosphorylation at this amino acid site (30) . Also, phosphorylation of myosin light chain II (MLC-2) at Thr-18 and Ser-19, which positively regulates actomyosin contractility, plays a central role in the remodeling of the cytoskeleton and adhesive contacts in response to external stimuli (30, 31) . Therefore, we next investigated the extent to which matrix oxidation and disruption of cell-matrix adhesion by endothelial-localized MPO was linked with changes in the phosphorylation status of paxillin and MLC-2.
Exposure of MPO-containing ECs to H2O2 at ≥10 μM triggered a time-dependent increase in the phosphorylation of paxillin at Tyr-118 that was apparent after 2 min oxidant addition and maintained up until 15 min before returning to baseline levels at 30 min (FIGS. 7A, B) . Exposure of MPO-containing ECs to lower H2O2 doses (5 μM), where EC adhesion was largely maintained (FIG. 6A) , resulted in a time-dependent decrease in paxillin Tyr-118 phosphorylation (FIG. 7B) . No alteration in paxillin phosphorylation was observed in control ECs exposed to equivalent doses of H2O2 in the absence of MPO (FIG. 7A) . The dose-dependent modulation of paxillin phosphorylation by MPO (i.e., down-regulation at low oxidant dose or up-regulation at higher oxidant dose) was prevented by Met and suppressed in the presence of SCN -and NO2 -plus Met (FIGS. 7C), identifying HOCl as the primary signaling oxidant produced by EC-localized MPO.
Tyr-118 of paxillin is a phosphorylation target for FAK or Src kinase (32) . In MPO-containing ECs exposed to H2O2, while no marked change in Tyr-397 phosphorylated and hence activated FAK was apparent (FIG. 7A) , exposure of these cells to 25 μM H2O2 resulted in the time-dependent increase in phosphorylation of Src at its activation/auto-phosphorylation site Tyr-416 that paralleled the time-dependent increase in paxillin Tyr-118 phosphorylation (FIGS. 7A, C). Activation of Src by Tyr-416 phosphorylation can involve de-phosphorylation of an inhibitory phosphorylation site (Tyr-527) (33) . Src Tyr-416 phosphorylation and paxillin Tyr-118 phosphorylation in MPO-containing ECs exposed to 25 μM H2O2 were not initially linked with Src Tyr-527 de-phosphorylation, however decreases in Tyr-527 phosphorylation were observed after 15 -30 min (FIG. 7C) . Src Tyr-416 phosphorylation and Tyr-527 de-phosphorylation were both prevented by Met and suppressed in the presence of SCN − or NO2 − plus Met (FIG. 7C) . A role of Src kinase for HOCl-dependent paxillin phosphorylation was indicated by the ability of the Src kinase inhibitor PP2 to block both basal and MPO-induced paxillin Tyr-118 phosphorylation (FIG. 7D) .
With respect to myosin II signaling, exposure of MPO-containing ECs to H2O2 resulted in the dose- (FIG. 7A) and time-dependent (FIG. 7B) increase in the cellular levels of di-phosphorylated MLC-2 (Tyr-18/Ser-19). MPO-induced MLC-2 phosphorylation was inhibited by addition of Met or SCN -or NO2 -plus Met (FIG. 7C) , confirming its dependence on HOCl, and was prevented by inhibiting Rho kinase with Y-27632 (FIG. 7E) . Y-27632 did not suppress HOCl-mediated fibronectin oxidation, confirming that its activity reflected its action as a Rho kinase inhibitor (FIG.  7E) .
EC de-adhesion induced by subendothelial MPO is dependent on actomyosin contractility-
The preceding studies identify that HOCl produced by subendothelial-localized MPO elicits Rho kinasedependent MLC-2 phosphorylation, which signals for increased myosin II-dependent contractility, and alters Src-dependent paxillin phosphorylation. We next examined the potential functional role of these signaling events in MPO-induced deadhesion by employing pharmacological inhibitors of myosin II signaling and Src-dependent paxillin phosphorylation. Changes in EC adhesion were quantified over time by cell-substrate impedance and/or by measuring decreases in the projected area of individual cells by image analysis of timelapse DIC movies.
Src inhibition with PP2 had no impact on the rate of MPO-induced de-adhesion (FIG. 8B) , indicating that while Src-dependent paxillin phosphorylation is a signaling response linked with de-adhesion it does not directly contribute to it. In contrast, inhibition of myosin II motor function with blebbistatin markedly abrogated membrane retraction from the substratum and from adjacent cells in MPO-containing ECs exposed to H2O2, both in ECs containing transcytosed MPO (FIG. 8A-D (FIG. 7E) , confirming that its inhibitory activity reflected its action as an inhibitor of myosin II motor function.
The rates of membrane retraction in individual cells during MPO-induced de-adhesion (measured as decreases in projected cell area over time) were quite uniform, with losses in cell area plateauing at ca. 50% of initial values and cells exhibiting average contraction half-lives of ca. 1 -2 min both in ECs containing transcytosed MPO (FIGS. 8C, D) and in ECs adhered on MPO-bearing fibronectin (Supplementary FIGS. 4C, D) . Of note, robust increases in Rho kinase-dependent MLC-2 phosphorylation occurred only after 5 min, when membrane retraction was already extensive (FIG. 7B) . Furthermore, Rho kinase inhibition (Y-27632) did not suppress the initial rapid phase of de-adhesion (<5 min following H2O2 exposure) and was protective only during the subsequent phase of de-adhesion (>5 min following H2O2 exposure) (FIGS. 8A, B) when Rho kinasedependent MLC-2 phosphorylation was increased (cf . FIG. 7B) .
Staining of MPO-containing ECs for F-actin and paxillin prior to (Supplementary FIG. 5A ) and 10 min following H2O2 exposure ( Supplementary FIG. 5B) showed that deadhesion involved extensive inward remodeling of the actin cytoskeleton and accumulation of F-actin and paxillin at the membrane periphery, with these effects abrogated by HOCl scavenging with Met ( Supplementary FIG. 5C ). Although Rho kinasedependent MLC-2 phosphorylation peaked within 5 -15 min following H2O2 exposure (FIG. 7B) , this was not accompanied by an increase in long actin stress fibres and instead de-adhesion was characterized by a loss of pre-existing stress fibres (Supplementary FIGS. 5A, B) .
Overall, these findings support that while upregulation of Rho kinase-dependent contractility contributes to the overall extent of MPO-induced de-adhesion, the initial, rapid phase of membrane retraction represents a response to oxidative disruption of cell-matrix contacts by MPO-derived HOCl, and is primarily driven by pre-existing stress in the actin cytoskeleton.
DISCUSSION
During vascular inflammation, MPO is released from activated leukocytes and accumulates within the subendothelial extracellular matrix by binding to and transcytosing the endothelium (12, 19) . Compelling clinical and experimental evidence has identified endothelial-transcytosed MPO as a key mediator of impaired NO signaling in inflammatory vascular responses and in human cardiovascular disease, with this thought to reflect its ability to efficiently intercept and oxidatively consume endothelial-derived NO within the subendothelial space (7, 10, 11) . However, subendothelial-localized MPO is also anatomically positioned to impact on endothelial morphology and signaling by oxidatively modifying the structure and function of adhesive extracellular matrix proteins (12, 15, 16) .
This study shows for the first time that subendothelial-localized MPO utilizes low micromolar concentrations of H2O2 to mediate targeted, HOCl-dependent oxidation of the subendothelial matrix, with this involving covalent modification/crosslinking of matrix fibronectin. Employing real time cell-substrate impedance biosensor measurements and quantitative live cell image analysis, we showed that HOCl-mediated oxidation of the subendothelial matrix triggers rapid retraction of the cell membrane from the substratum and from adjacent ECs (de-adhesion). EC de-adhesion was linked with the activation of Src and modulation of Tyr-118 phosphorylation of paxillin, a key focal adhesion-dependent signaling process, as well as Rho kinase-dependent MLC-2 phosphorylation. Of these signaling events, MPOinduced EC de-adhesion were dependent on the actomyosin contractile machinery as inhibition of myosin II and Rho kinase-mediated MLC-2 phosphorylation significantly reduced the overall rate of membrane retraction.
Previous studies have shown that transcytosed MPO associates basolaterally with fibronectin and locally catabolizes NO2 -to the nitrating radical NO2  , conferring specificity of MPO-mediated protein tyrosine nitration to fibronectin (12) . Immunohistochemical studies support that fibronectin is an important target for MPO-derived NO2  in inflammatory vascular disorders, with MPO, fibronectin and tyrosine nitrated proteins having been shown to co-localize in diseased human vessels (19) . However, the functional implications of NO2  production within the endothelium by MPO have not been previously investigated. The current study reveals that in the presence of NO2 -subendothelial MPO concomitantly catalyzes HOCl-dependent crosslinking and tyrosine nitration of matrix fibronectin. However, HOCl-mediated reactions were shown to be primarily responsible for triggering EC de-adhesion and associated cell signaling events: Scavenging of HOCl with Met markedly attenuated fibronectin crosslinking and cell signaling responses, but did not prevent fibronectin nitration.
Another biologically important MPO substrate is SCN − , which is derived primarily from dietary sources (e.g., broccoli) and is elevated in smokers. Currently, there is considerable interest in whether diversion of MPO from HOCl production by SCN − to instead produce the thiol-reactive oxidant HOSCN is protective or deleterious in the context of inflammatory vascular conditions (34, 35) . Our finding that SCN -accelerates H2O2 metabolism yet suppresses HOCl production by EC-localized MPO is indicative of local production of HOSCN. Despite this, SCN − supplements were protective against MPO-induced EC de-adhesion and associated signaling responses, indicating the HOSCN produced by subendothelial MPO is functionally silent in this regard. These findings are consistent with other findings that identify a protective, antioxidant function for SCN − against MPO-mediated EC injury (34) .
Model studies employing purified fibronectin as the sole adhesive substrate provided strong evidence that induction of EC de-adhesion by MPO-derived HOCl involves disruption of the cell-adhesive function of fibronectin. Thus, oxidation of fibronectin by MPO-derived HOCl readily impaired its ability to support EC attachment and spreading and this loss in function correlated well with the capacity of HOCl, produced at the basolateral surface of ECs by fibronectin-bound MPO, to disrupt established EC adhesion on fibronectin. In accordance with their ability to suppress HOCl-mediated fibronectin modification/crosslinking, SCN − and NO2 − prevented MPO-induced impairment of attachment and spreading of ECs on, and de-adhesion of ECs from fibronectin.
Whilst our data identify a causal role for HOCl-mediated matrix oxidation in triggering EC de-adhesion, we showed that actomyosin tensile forces significantly accelerate this process. Thus, the rate of de-adhesion triggered by H2O2 exposure in MPO-containing ECs was markedly attenuated by the inhibition of myosin II motor function with blebbistatin. Up-regulation of Rho kinasedependent contractility contributed to the MPOinduced EC de-adhesion, but not during the initial rapid phase of membrane retraction, which preceded robust increases in Rho kinasedependent MLC-2 phosphorylation and was not attenuated by Rho kinase inhibition.
Our data support a model where subendothelial-localized MPO catalyzes targeted, HOCl-mediated matrix oxidation that disrupts adhesive forces at the cell-matrix interface to trigger membrane retraction driven by pre-existing tensile force within the actin cytoskeleton (SCHEME 1A, B). Notably, other recent studies identify that targeted disruption of cell-matrix contacts by electrochemical means likewise provokes rapid cell contraction driven by preexisting actomyosin tensile stress (36) .
As well as mechanically coupling the actin cytoskeleton to the subendothelial matrix, adhesive contacts are enriched in cytoplasmic signaling proteins and rapidly transduce mechanical signals provided by changes in cellmatrix adhesion into intracellular phosphorylation events. This 'outside-in' signaling, in which paxillin phosphorylation plays a central regulatory role, allows cells to respond rapidly and sensitively to chemical and physical changes in the extracellular matrix and engages signaling networks that control cell shape, motility, proliferation and survival (28) (29) (30) (31) .
We propose that the focal disruption of cellmatrix contacts by HOCl in the subendothelium drives signaling changes by altering cell-matrix mechanotransduction (SCHEME 1C). Paxillin Tyr-118 phosphorylation is negatively regulated by force transduction at focal adhesions (i.e. cellmatrix traction) (30) and the increase in phosphorylation observed at this site at higher oxidant doses is fully consistent with a global loss in cell-matrix traction triggered by HOClmediated matrix oxidation. Phosphorylation of paxillin at Tyr-118 generates docking sites for SH2 domain containing proteins (29) and engages signaling networks that regulate the assembly of new adhesive contacts (30) . Notably, the levels of paxillin phosphorylation were initially maintained and chronically down-regulated during deadhesion at lower oxidant doses, where matrix oxidation and de-adhesion was less extensive, with this consistent with compensatory increases in cell-matrix traction at pre-existing and/or newly formed adhesive contacts (30) .
Another important novel aspect of this work is the finding that HOCl produced subendothelially by MPO induces Rho kinase-dependent MLC-2 di-phosphorylation at Tyr-18 and Ser-19, and Src activation as indexed by Tyr-416 phosphorylation and Tyr-527 de-phosphorylation. Together with alterations in paxillin phosphorylation, MLC-2 phosphorylation and Src activation represent key signaling processes involved in adhesion responses (30, 31) . The specificity of these responses to the action of MPO-derived HOCl indicates that they may be functionally linked to changes in cell-matrix mechanotransduction (see discussion below). Notably, previous studies identify that loss of cell adhesion alone can trigger increases in Src activation and paxillin phosphorylation (37, 38) .
Significantly, no previous study has addressed the possibility that oxidants might drive changes in cell signaling by altering cell-matrix mechanotransduction. Our proposed model of 'outside-in' redox signaling (SCHEME 1) differs from the conventional model of redox signaling in that it involves oxidants modifying extracellular proteins and generating mechanical signals to propagate intracellular phosphorylation events instead of directly modifying and altering the activity of intracellular signaling proteins.
We do not exclude that 'conventional' redox signaling mechanisms contribute to the signaling responses elicited by subendothelial-localized MPO. HOCl could contribute to the observed signaling responses (paxillin Tyr-118 phosphorylation, Src Tyr-118 phosphorylation/ Tyr-527 de-phosphorylation or MLC-2 Tyr-18/ Ser-19 phosphorylation), by directly oxidizing critical cysteine residues present on RhoA (which activates Rho kinase) and Src, leading to their activation (33, 39, 40) or by oxidizing active site cysteines in regulatory protein phosphatases. However, given that HOSCN is predominantly a thiol-selective oxidant (18) , the ability of SCN -to suppress these signaling responses is not consistent with a role for conventional redox signaling as if the case the formation of HOSCN by EC-localized MPO would also be expected to promote the relevant signaling events. Furthermore, kinetic considerations on the reactivity of oxidants predicts that HOCl exerts its biological effects by oxidizing targets within a very short distance of its site of production (41). In line with this prediction, our current data identifies that HOCl produced by endothelial-transcytosed MPO mediates focal oxidation of matrix proteins within the subendothelial compartment to alter adhesion and adhesion-dependent signaling. We propose that this involves HOCl-mediated impairment of the function of the cell-adhesion (integrin-and/or heparin-binding) motifs of fibronectin. Indeed, the lack of cysteine and tyrosine residues in these adhesion motifs, and hence their resistance to functional damage by HOSCN and NO2
 , could explain why diversion of MPO from HOCl production by SCN -and NO2 -was protective against de-adhesion and associated signaling responses. Physiological redox signaling processes are increasingly recognized to be highly regulated, involving targeted, oxidative modification of specific proteins, with signaling specificity achieved through spatial association of oxidantgenerating enzymes and target proteins within specific cellular compartments (1, 42) . Interestingly, the alteration of endothelial signaling by subendothelial matrix-bound MPO fits within this paradigm. It is therefore tempting to speculate that the delivery of MPO to the subendothelial compartment by endothelialtranscytosis to promote HOCl-mediated matrix oxidation might serve an unforseen regulatory function during inflammatory vascular responses. However, its potential pathophysiological significance is clear: Our present findings identify that matrix oxidation resulting from the production of low, physiological fluxes of HOCl by subendothelial-localized MPO triggers a rapid loss in endothelial cell-matrix adhesion and increase in membrane retraction, events that will significantly perturb the integrity of the endothelium. These processes could play a key pathological role in inflammatory vascular conditions by promoting tissue oedema and compromising the antiinflammatory/anti-thrombogenic function of the endothelium by exposing intimal proteins. 
